SUMO-1 protease-1 regulates gene transcription through PML

Molecular Cell

Volumn 10, Issue 4, 2002, Pages 843-855

  Best, Jennifer L ^a   Ganiatsas, Soula ^a   Agarwal, Sadhana ^a   Changou, Austin ^b   Salomoni, Paolo ^b   Shirihai, Orian ^a   Meluh, Pamela B ^b   Pandolfi, Pier Paolo ^b   Zon, Leonard I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRINASE; DAXX PROTEIN; PROTEIN; PROTEIN CBP; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PHOSPHORYLATION; PROMYELOCYTIC LEUKEMIA; SUPR 1 GENE; TRANSCRIPTION REGULATION;

EID: 0036809116     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00699-8     Document Type: Article

References (51)

1. Ahn J.H., Brignole E.J. III, Hayward G.S. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell. Biol. 18:1998;4899-4913.
2. Bannister A.J., Oehler T., Wilhelm D., Angel P., Kouzarides T. Stimulation of c-Jun activity by CBP. c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro Oncogene. 11:1995;2509-2514.
3. Boisvert F.M., Hendzel M.J., Bazett-Jones D.P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148:2000;283-292.
4. Borden K.L. Pondering the promyelocytic leukemia protein (PML) puzzle. possible functions for PML nuclear bodies Mol. Cell. Biol. 22:2002;5259-5269.
5. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1. a protein kinase stimulated by uv light and ha-ras that binds and phosphorylates the c-jun activation domain Cell. 76:1994;1025-1037.
6. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell. 2:1998;233-239.
7. Doucas V., Brockes J.P., Yaniv M., de The H., Dejean A. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Proc. Natl. Acad. Sci. USA. 90:1993;9345-9349.
8. Doucas V., Tini M., Egan D.A., Evans R.M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA. 96:1999;2627-2632.
9. Everett R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene. 20:2001;7266-7273.
10. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112:1999;4581-4588.
11. Gong L., Millas S., Maul G.G., Yeh E.T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275:2000;3355-3359.
12. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18:1999;6462-6471.
13. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Pandolfi P.P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2:2000;730-736.
14. Hang J., Dasso M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277:2002;19961-19966.
15. Hardingham G.E., Chawla S., Cruzalegui F.H., Bading H. Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron. 22:1999;789-798.
16. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss J.F. III, Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:1999;221-234.
17. Johnson E.S., Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272:1997;26799-26802.
18. Kadoya T., Kishida S., Fukui A., Hinoi T., Michiue T., Asashima M., Kikuchi A. Inhibition of Wnt signaling pathway by a novel axin-binding protein. J. Biol. Chem. 275:2000;37030-37037.
19. Kadoya T., Yamamoto H., Suzuki T., Yukita A., Fukui A., Michiue T., Asahara T., Tanaka K., Asashima M., Kikuchi A. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin. Mol. Cell. Biol. 22:2002;3803-3819.
20. Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., Yeh E.T. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273:1998;26675-26682.
21. Kim K.I., Baek S.H., Jeon Y.J., Nishimori S., Suzuki T., Uchida S., Shimbara N., Saitoh H., Tanaka K., Chung C.H. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275:2000;14102-14106.
22. Kim K.I., Baek S.H., Chung C.H. Versatile protein tag, SUMO. its enzymology and biological function J. Cell. Physiol. 191:2002;257-268.
23. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
24. LaMorte V.J., Dyck J.A., Ochs R.L., Evans R.M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95:1998;4991-4996.
25. Li S.J., Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature. 398:1999;246-251.
26. Li S.J., Hochstrasser M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol. Cell. Biol. 20:2000;2367-2377.
27. Li H., Leo C., Zhu J., Wu X., O'Neil J., Park E.J., Chen J.D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20:2000;1784-1796.
28. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88:1997;97-107.
29. Mahajan R., Gerace L., Melchior F. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140:1998;259-270.
30. Matunis M.J., Wu J., Blobel G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140:1998;499-509.
31. Melnick A., Licht J.D. Deconstructing a disease. RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood. 93:1999;3167-3215.
32. Mossessova E., Lima C.D. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell. 5:2000;865-876.
33. Muller S., Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73:1999;5137-5143.
34. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
35. Muller S., Berger M., Lehembre F., Seeler J., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:2000;13321-13329.
36. Negorev D., Maul G.G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene. 20:2001;7234-7242.
37. Nishida T., Tanaka H., Yasuda H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267:2000;6423-6427.
38. Nishida T., Kaneko F., Kitagawa M., Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat Axam, which is an Axin-binding protein promoting beta-catenin degradation. J. Biol. Chem. 276:2001;39060-39066.
39. Rahmsdorf H.J. Jun. transcription factor and oncoprotein J. Mol. Med. 74:1996;725-747.
40. Rizos H., Darmanian A.P., Mann G.J., Kefford R.F. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene. 19:2000;2978-2985.
41. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
42. Ross S., Best J.L., Zon L.I., Gill G. SUMO-1 modification represses Sp3 transcription activation and modulates its subnuclear localization. Mol. Cell. 10:2002;831-842. this issue,
43. Sternsdorf T., Jensen K., Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139:1997;1621-1634.
44. Taylor D.L., Ho J.C., Oliver A., Watts F.Z. Cell-cycle-dependent localisation of Ulp1, a Schizosaccharomyces pombe Pmt3 (SUMO)-specific protease. J. Cell Sci. 115:2002;1113-1122.
45. Vallian S., Gaken J.A., Gingold E.B., Kouzarides T., Chang K.S., Farzaneh F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene. 16:1998;2843-2853.
46. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
47. Zhang H., Saitoh H., Matunis M.J. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22:2002;6498-6508.
48. Zhong S., Delva L., Rachez C., Cenciarelli C., Gandini D., Zhang H., Kalantry S., Freedman L.P., Pandolfi P.P. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat. Genet. 23:1999;287-295.
49. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood. 95:2000;2748-2752. a.
50. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:2000;E85-E90. b.
51. Zhong S., Salomoni P., Ronchetti S., Guo A., Ruggero D., Pandolfi P.P. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J. Exp. Med. 191:2000;631-640. c.